PWE Stock Chart & Stats
€0.13
<€0.01(0.93%)
At close: 4:00 PM EST
€0.13
<€0.01(0.93%)
Day’s Range― - ―
52-Week Range€0.08 - €0.17
Previous CloseN/A
Volume0.00
Average Volume (3M)5.00
Market Cap
€145.00M
Enterprise Value€506.82
Total Cash (Recent Filing)€1.83B
Total Debt (Recent Filing)€21.03M
Price to Earnings (P/E)27.1
Beta0.16
Next Earnings
Apr 01, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding1,433,241,100
10 Day Avg. Volume0
30 Day Avg. Volume5
Financial Highlights & Ratios
PEG Ratio-0.51
Price to Book (P/B)0.44
Price to Sales (P/S)2.13
P/FCF Ratio12.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Very Low LeverageThe exceptionally low debt burden gives PW Medtech substantial financial flexibility and reduces exposure to interest costs or refinancing pressure. A conservative balance sheet can help the company preserve capital, withstand operating volatility, and fund future needs without relying heavily on external borrowing.
Positive Cash GenerationPositive operating and free cash flow show that the business continues to generate cash internally despite weaker recent performance. This supports ongoing operations, capital allocation, and resilience, while providing a foundation for investment or shareholder returns over the next several quarters.
Established Profitability And MarginsThe company’s history of strong growth and high gross margins indicates an established operating model with meaningful value capture. Although recent results weakened, this prior profitability provides a durable base from which management can stabilize performance and rebuild earnings quality.
Bears Say
Revenue And Margin ContractionThe simultaneous decline in revenue and profitability signals weaker operating momentum and reduces confidence in near-term earnings durability. Sustained margin compression would limit internal reinvestment capacity, weaken operating leverage, and make recovery dependent on restoring both demand and profitability.
Volatile Free Cash FlowAlthough cash generation remains positive, repeated year-over-year weakening makes the company’s cash profile less predictable. Volatility can constrain the timing of investment and shareholder distributions, while reducing confidence that reported profits will consistently translate into expanding financial resources.
Modest Returns On EquityLow returns on a large equity base indicate that the company is not currently using its conservative capital structure efficiently. If profitability remains modest, excess capital may generate limited value and earnings growth may stay subdued despite the balance sheet’s financial strength.
PW Medtech Group Ltd. News
PWE FAQ
What was PW Medtech Group Ltd.’s price range in the past 12 months?
PW Medtech Group Ltd. lowest stock price was €0.08 and its highest was €0.17 in the past 12 months.
What is PW Medtech Group Ltd.’s market cap?
PW Medtech Group Ltd.’s market cap is €145.00M.
When is PW Medtech Group Ltd.’s upcoming earnings report date?
PW Medtech Group Ltd.’s upcoming earnings report date is Apr 01, 2027 which is in 185 days.
How were PW Medtech Group Ltd.’s earnings last quarter?
PW Medtech Group Ltd. released its earnings results on Aug 28, 2026. The company reported €0.001 earnings per share for the quarter.
Is PW Medtech Group Ltd. overvalued?
According to Wall Street analysts PW Medtech Group Ltd.’s price is currently Overvalued.
Does PW Medtech Group Ltd. pay dividends?
PW Medtech Group Ltd. does not currently pay dividends.
What is PW Medtech Group Ltd.’s EPS estimate?
PW Medtech Group Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PW Medtech Group Ltd. have?
PW Medtech Group Ltd. has 1,433,241,100 shares outstanding.
What happened to PW Medtech Group Ltd.’s price movement after its last earnings report?
PW Medtech Group Ltd. reported an EPS of €0.001 in its last earnings report. Following the earnings report the stock price went up 1.205%.
Which hedge fund is a major shareholder of PW Medtech Group Ltd.?
Currently, no hedge funds are holding shares in DE:PWE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
PW Medtech Group Ltd.
Operating within the People's Republic of China, PW Medtech Group Limited is an investment holding company primarily engaged in the medical device industry. The company specializes in the manufacturing and distribution of a diverse portfolio of medical consumables, including various types of infusion sets such as non-PVC, precision filter, and light-resistant models, alongside intravenous cannula products and insulin needles and pens. Beyond its core medical device activities, the group also provides property management services. Established in 1997, the company, previously known as Pyholding Limited, maintains its corporate headquarters in Beijing, China.
Technical Analysis
Shandong Weigao Group Medical Polymer Co
―
Modern Dental Group Limited
―
Shanghai Kindly Medical Instruments Co., Ltd. Class H
―
Angelalign Technology Inc.
―
OrbusNeich Medical Group Holdings Limited
―